2023 Maserati Levante GT

3.0 L • 6 • 4×4 • AT

ZN661XUA9PX411559

Highlights
Condition
Not provided
Seller
Insurance • USAA
Key included
Yes
Docs
Good
History
1 record
Drive
3.0 L • 6 • 4×4 • AT
Odometer
32,528 mi ≈ 52,349 km
Primary damage
Front end
Secondary damage
Rear end
Docs
TX • Salvage
Extra
Auction
VIN
ZN661XUA9PX411559
Lot number
52242265
Copart
Sale status
Sold
Seller type
Insurance
Seller
USAA
Location
Dallas, TX
Description
Fuel type
Gasoline
Body color
White
Trim
GT
All sales final. Always run reports before bid

Sharing our own experience

Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.

How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides

Popular Maserati models

BiturboGhibliGranTurismo
GrecaleLevanteMC20
Quattroporte

2023 Maserati Levante GT • 3.0 L • 6 cyl • 4×4 • Automatic • Copart Lot: 52242265 • VIN: ZN661XUA9PX411559

Find out more about this 2023 Maserati Levante GT, available at the Copart salvage car auction as lot 52242265 in Dallas, TX. This car has Front end main damage. It is listed with Not provided start condition code. Odometer shows 32,528 mi. This White Maserati Levante is equipped with Gasoline 3.0 L engine, 4×4 drivetrain, Automatic transmission. Check the vehicle history report for ZN661XUA9PX411559 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.

We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.